Market Overview:
The global macular degeneration and other retinal diseases market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market is segmented by type, application, and region. By type, the market is divided into macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), retinal vein occlusion (RVO), wet age-related macular degeneration (wAMD), dry age-related macular degeneration (dAMD) and other retinal diseases. The AMD segment accounted for the largest share of the global market in 2017 owing to the high prevalence of this disease across all regions. By application, the hospital segment accounted for the largest share of the global market in 2017 owing to increased awareness about eye health and rising incidence of eye disorders among people worldwide.
 and Other Retinal Diseases Industry Outlook.svg)
Product Definition:
Macular degeneration is a disease of the eye that affects the macula. The macula is a small area in the center of the retina that is responsible for clear, sharp vision. Macular degeneration causes progressive damage to this area, which can lead to vision loss. There are two types of macular degeneration: dry and wet. Wet macular degeneration is more serious and can lead to rapid vision loss. Other retinal diseases include diabetic retinopathy, glaucoma, and retinitis pigmentosa.
Macular Degeneration:
Macular degeneration is a progressive disorder of the macula, which is located in the center of the retina. The macula acts as a photoreceptor and is responsible for central vision. As people age, their retinal surface changes; this change includes loss of photoreceptors and nerve fiber layer around the central area called “macular” or “central" region (Latin: macula).
Diabetic Macular Edema:
Diabetic macular edema is a type of diabetic eye disease that affects the macula, which is located in the center of the retina and plays an important role in vision. The disease develops when there is an increase in fluid pressure within the eye due to high blood sugar (hyperglycemia), leading to retinal neovascularization with leakage of serum and other inflammatory components.
Application Insights:
The other application segment includes the study of macular degeneration and other retinal diseases. The prevalence of AMD and DR is increasing at a significant rate, which can be attributed to the growing aging population in developing countries such as China, India, Brazil etc. Moreover, an increase in number of research studies supporting its treatment for wet AMD is expected to drive growth during the forecast period.
Clinical trials are ongoing for its clinical trial evidence base for treating wet AMD with intravitreal injections of anti-VEGF drugs (tamoxifen citrate &ranolastum) or laser therapy (photodynamic therapy).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of key players, favorable reimbursement policies, and increasing healthcare expenditure are some factors driving the growth. In addition, rise in awareness about early diagnosis is expected to fuel regional growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate owing to increase in prevalence of retinal diseases coupled with growing medical tourism industry and improving healthcare infrastructure especially eye care facilities across emerging countries such as China & India & South Korea etcetera in this region alone around 1 million people suffer from macular degeneration which leads them for surgery operation every year thus creating huge demand for these devices thus fueling regional growth over the forecast period.
Growth Factors:
- Increasing aging population: The global aging population is increasing at a rapid pace. This will lead to an increase in the number of people affected by macular degeneration and other retinal diseases.
- Rise in awareness about eye health: There is a growing awareness among people about the importance of eye health and the prevention of vision loss. This is likely to lead to an increase in demand for treatments for macular degeneration and other retinal diseases.
- Technological advancements: There has been significant progress in technology-based treatments for macular degeneration and other retinal diseases in recent years, which is likely to drive market growth over the forecast period.
- Growing prevalence of obesity: Obesity has been linked with an increased risk of developing various eye conditions, including macular degeneration and diabetic retinopathy. As obesity rates continue to rise globally, this will contribute significantly to market growth over the forecast period . 5) Rising healthcare expenditure: Globally, there has been a steady increase in healthcare expenditure over the past few years, owing largely to rising income levels across emerging economies
Scope Of The Report
Report Attributes
Report Details
Report Title
Macular Degeneration (AMD) and Other Retinal Diseases Market Research Report
By Type
Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy(DR), Retinal Vein Occlusion, Wet Age-Related Macular Degeneration (wAMD), Dry Age-Related Macular Degeneration (dAMD), Other, Macular Degeneration (AMD) and Other Retinal Disease
By Application
Hospital, Clinic, Other
By Companies
Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma, Merck, Allergan, Santen Pharmaceutical, GlaxoSmithKline Pharmaceuticals, Pfizer, Acucela, Valent Pharmaceuticals, IVERIC, Macular Degeneration (AMD) and Other Retinal Disease
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Report Segments:
The global Macular Degeneration (AMD) and Other Retinal Diseases market is segmented on the basis of:
Types
Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy(DR), Retinal Vein Occlusion, Wet Age-Related Macular Degeneration (wAMD), Dry Age-Related Macular Degeneration (dAMD), Other, Macular Degeneration (AMD) and Other Retinal Disease
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Regeneron Pharmaceuticals
- Bayer HealthCare
- Novartis
- Roche
- Kanghong Pharma
- Merck
- Allergan
- Santen Pharmaceutical
- GlaxoSmithKline Pharmaceuticals
- Pfizer
- Acucela
- Valent Pharmaceuticals
- IVERIC
- Macular Degeneration (AMD) and Other Retinal Disease
 and Other Retinal Diseases Market Overview.svg)
Highlights of The Macular Degeneration (AMD) and Other Retinal Diseases Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Macular Degeneration
- Diabetic Macular Edema
- Diabetic Retinopathy(DR)
- Retinal Vein Occlusion
- Wet Age-Related Macular Degeneration (wAMD)
- Dry Age-Related Macular Degeneration (dAMD)
- Other
- Macular Degeneration (AMD) and Other Retinal Disease
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Macular Degeneration (AMD) and Other Retinal Diseases Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 and Other Retinal Diseases Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Macular degeneration is a leading cause of blindness in the United States. It is a progressive disease that affects the central part of your retina, which helps you see clearly. Other retinal diseases include age-related macular degeneration (AMD), diabetic macular edema (DME), and neovascular AMD.
Some of the major companies in the macular degeneration (amd) and other retinal diseases market are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma, Merck, Allergan, Santen Pharmaceutical, GlaxoSmithKline Pharmaceuticals, Pfizer, Acucela, Valent Pharmaceuticals, IVERIC, Macular Degeneration (AMD) and Other Retinal Disease.
The macular degeneration (amd) and other retinal diseases market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Macular Degeneration (AMD) and Other Retinal Diseases Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Macular Degeneration (AMD) and Other Retinal Diseases Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Macular Degeneration (AMD) and Other Retinal Diseases Market - Supply Chain
4.5. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast
4.5.1. Macular Degeneration (AMD) and Other Retinal Diseases Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Macular Degeneration (AMD) and Other Retinal Diseases Market Size (000 Units) and Y-o-Y Growth
4.5.3. Macular Degeneration (AMD) and Other Retinal Diseases Market Absolute $ Opportunity
5. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Type
5.3.1. Macular Degeneration
5.3.2. Diabetic Macular Edema
5.3.3. Diabetic Retinopathy(DR)
5.3.4. Retinal Vein Occlusion
5.3.5. Wet Age-Related Macular Degeneration (wAMD)
5.3.6. Dry Age-Related Macular Degeneration (dAMD)
5.3.7. Other
5.3.8. Macular Degeneration (AMD) and Other Retinal Disease
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Macular Degeneration (AMD) and Other Retinal Diseases Demand Share Forecast, 2019-2026
9. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Type
9.7.1. Macular Degeneration
9.7.2. Diabetic Macular Edema
9.7.3. Diabetic Retinopathy(DR)
9.7.4. Retinal Vein Occlusion
9.7.5. Wet Age-Related Macular Degeneration (wAMD)
9.7.6. Dry Age-Related Macular Degeneration (dAMD)
9.7.7. Other
9.7.8. Macular Degeneration (AMD) and Other Retinal Disease
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Macular Degeneration (AMD) and Other Retinal Diseases Demand Share Forecast, 2019-2026
10. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Type
10.7.1. Macular Degeneration
10.7.2. Diabetic Macular Edema
10.7.3. Diabetic Retinopathy(DR)
10.7.4. Retinal Vein Occlusion
10.7.5. Wet Age-Related Macular Degeneration (wAMD)
10.7.6. Dry Age-Related Macular Degeneration (dAMD)
10.7.7. Other
10.7.8. Macular Degeneration (AMD) and Other Retinal Disease
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Demand Share Forecast, 2019-2026
11. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Macular Degeneration (AMD) and Other Retinal Dseases Market Size and Volume Forecast by Type
11.7.1. Macular Degeneration
11.7.2. Diabetic Macular Edema
11.7.3. Diabetic Retinopathy(DR)
11.7.4. Retinal Vein Occlusion
11.7.5. Wet Age-Related Macular Degeneration (wAMD)
11.7.6. Dry Age-Related Macular Degeneration (dAMD)
11.7.7. Other
11.7.8. Macular Degeneration (AMD) and Other Retinal Disease
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Macular Degeneration (AMD) and Other Retinal Diseases Demand Share, 2019-2026
12. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Type
12.7.1. Macular Degeneration
12.7.2. Diabetic Macular Edema
12.7.3. Diabetic Retinopathy(DR)
12.7.4. Retinal Vein Occlusion
12.7.5. Wet Age-Related Macular Degeneration (wAMD)
12.7.6. Dry Age-Related Macular Degeneration (dAMD)
12.7.7. Other
12.7.8. Macular Degeneration (AMD) and Other Retinal Disease
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Demand Share, 2019-2026
13. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size and Volume Forecast by Type
13.7.1. Macular Degeneration
13.7.2. Diabetic Macular Edema
13.7.3. Diabetic Retinopathy(DR)
13.7.4. Retinal Vein Occlusion
13.7.5. Wet Age-Related Macular Degeneration (wAMD)
13.7.6. Dry Age-Related Macular Degeneration (dAMD)
13.7.7. Other
13.7.8. Macular Degeneration (AMD) and Other Retinal Disease
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Macular Degeneration (AMD) and Other Retinal Diseases Market: Market Share Analysis
14.2. Macular Degeneration (AMD) and Other Retinal Diseases Distributors and Customers
14.3. Macular Degeneration (AMD) and Other Retinal Diseases Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Regeneron Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer HealthCare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Kanghong Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Allergan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Santen Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GlaxoSmithKline Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Acucela
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Valent Pharmaceuticals
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. IVERIC
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Macular Degeneration (AMD) and Other Retinal Disease
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview<
